首页> 外文期刊>The Journal of toxicological sciences >Alleviating effects of artificial tear instillation on S-1-induced ocular toxicity in dogs
【24h】

Alleviating effects of artificial tear instillation on S-1-induced ocular toxicity in dogs

机译:人工撕裂滴注对犬S-1诱导眼科毒性的影响

获取原文
获取原文并翻译 | 示例
           

摘要

S-1 is an anticancer agent that consists of tegafur, gimeracil, and oteracil potassium at a molar ratio of 1:0.4:1. S-1 is used to treat metastatic and resectable gastric cancer. However, the extensive use of S-1 in clinical practice results in watery eyes, a serious clinical problem, which worsens patients' quality of life. Although repeated instillation of artificial tears is recommended, therapy or prophylaxis against S-1-induced ocular toxicity has not been established. In the present study, we evaluated the alleviating effects of repeated artificial tear instillation on S-1-induced ocular toxicity in dogs. Ten beagle dogs (5 males and 5 females) were orally administered 3 mg/kg/day of S-1 for up to 21 days. Five drops of artificial tears were instilled to the left eye, eight times daily, within 6 hr after S-1 administration. The mean cornea staining score tended to be low in the left eye with repeated artificial tear instillation. In 4 out of 10 dogs, the corneal staining score of the left eye was more than 2-fold lower than that of the right eye. The incidence of dogs indicating normal tear drainage increased and stenosed tear drainage decreased by repeated artificial tear instillation. In conclusion, we demonstrated that artificial tear instillation can alleviate corneal surface damage induced by S-1 in dogs.
机译:S-1是一种抗癌剂,由TEGAFUR,Gimeracil和Oteracil钾以1:0.4:1的摩尔比组成。 S-1用于治疗转移性和可重置胃癌。然而,S-1在临床实践中的广泛使用导致水汪汪的眼睛,一个严重的临床问题,患者患者的生活质量。虽然建议使用重复滴注人工撕裂,但尚未建立针对S-1诱导的眼部毒性的治疗或预防。在本研究中,我们评估了反复人工撕裂滴注对犬S-1诱导的眼部毒性的缓解作用。 10猎犬犬(5名男性和5名女性)口服给予3mg / kg /天的S-1最多21天。在S-1给药后6小时内每天滴到左眼八次的五滴的人工泪液。左眼中的平均角膜染色分数趋于较低,重复的人工撕裂滴注。在10只狗中有4个,左眼的角膜染色得分比右眼低2倍。通过反复的人工泪液滴注,狗的发病率增加和狭窄的撕裂引流减少。总之,我们证明人工撕裂滴注可以减轻S-1在狗中诱导的角膜表面损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号